Exchange rate hurting chronic drug suppliers – but ARV pipeline safe, says govt

Chris Bateman


The government has categorically denied that there is any danger of antiretroviral (ARV) drug supplies running short or drying up following a claim from one of their three suppliers, Aspen Pharmaceuticals, that insufficient relief on the dismal rand exchange rate and single exit price (SEP) is creating a net loss.

Author's affiliations

Chris Bateman, HMPG, South Africa

Full Text

PDF (103KB)


Antiretrovirals; Drug supplies; Exchange rate; Single exit price

Cite this article

South African Medical Journal 2014;104(7):461-463. DOI:10.7196/SAMJ.8540

Article History

Date submitted: 2014-06-08
Date published: 2014-06-10

Article Views

Abstract views: 1743
Full text views: 825

Comments on this article

*Read our policy for posting comments here